- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05190354
Post Market Clinical Protocol - Xtremity Polymer Prosthetic Socket System
August 22, 2022 updated by: Medical Creations, Inc.
Single-arm, prospective multi-center study assessing user preference of the Xtremity prosthetic socket in below the knee amputation prostheses.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Vancouver, Canada, VSX 2T4
- Barber Prosthetics
-
-
-
-
Arkansas
-
Little Rock, Arkansas, United States, 72205
- Snell Prosthetics and Orthotic Laboratory
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
19 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Male or female ≥ 19 years old
- Unilateral or bilateral transtibial amputation
- Subject has been informed of the nature of the study, agrees to participate and comply with all follow-up visits and has signed the consent form.
- Currently using a standard carbon fiber or high temperature thermoplastic prosthetic socket.
- Residual limb is between 26-34 cm circumference with a liner (when measured 4cm proximal to distal end)
- Subject is eligible for standard carbon fiber or high temperature thermoplastic prosthetic socket if necessary.
- Must be able to ambulate at least 100 yards with or without an assistive device.
- Must be able to don and doff a prosthesis independently.
- Estimated life expectancy > 1 year
Exclusion Criteria:
- Amputation < 6 months prior to enrollment
- Residual limb less than (<) 26cm and greater than (>) 34cm circumference at the distal end.
- Body weight greater than (>) 275lbs.
- Syme's amputations or total limb length over 30cm
- Some bulbous or irregular limb shapes
- Build height and circumference limitations
- Wounds or skin issues that preclude normal fit
- Unusual alignment of the socket or foot
- Alignment outside the capability of the Xtremity System.
- Planned for any major surgery within 6 months of enrollment.
- Subject is pregnant or breastfeeding
- Subject is incarcerated.
- Subject anticipates that the socket will frequently be subject to temperatures greater than 110 degrees F while in their possession.
- Subject anticipates that the socket will frequently be subject to direct sunlight
- Limb circumference at the mid-patella tendon exceeds the maximum circumference (see sizing chart in the instructions for use)
- Subject is participating in another research study of a device, medication, which could, in the opinion of the investigator, affect the results of this study.
- Subject has other medical, social or psychological problems that in the opinion of the investigator would preclude them from receiving this treatment and the procedures and or participating in evaluations pre and post-treatment.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Supportive Care
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Xtremity Prosthesis
Xtremity Prosthesis fitting
|
Subjects with transtibial unilateral or bilateral amputation who have experience using a standard carbon fiber or high temperature thermoplastic prosthetic socket will be evaluated and fitted with a below knee prosthesis socket
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
User Preference of the Xtremity Socket - Achievement of durability
Time Frame: 21 days
|
Device success defined as rate of achieving durability
|
21 days
|
|
User Preference of the Xtremity Socket - Socket Comfort Score
Time Frame: 21 Days
|
Rate of device success measured by Socket Comfort Score
|
21 Days
|
|
User Preference of the Xtremity Socket - Prosthetic Evaluation Questionnaire
Time Frame: 21 Days
|
Rate of device success measured by abbreviated Prosthetic Evaluation Questionnaire
|
21 Days
|
|
User Preference of the Xtremity Socket - Activity
Time Frame: 21 Days
|
Rate of device success measured by activity level ranked low activity to high activity (1-10)
|
21 Days
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Benefits to prosthetist - Casting Time
Time Frame: 21 days
|
Measured by time from casting to delivery in days
|
21 days
|
|
Benefits to prosthetist - Material Consumption
Time Frame: 21 days
|
Measured by amount of material consumed
|
21 days
|
|
Benefits to prosthetist - Material Waste
Time Frame: 21 days
|
Measured by amount of material wasted
|
21 days
|
|
Benefits to prosthetist - Resources
Time Frame: 21 days
|
Number of resources required to use
|
21 days
|
|
Benefits to prosthetist - Skill
Time Frame: 21 days
|
Level of skill set required to use ranked on a scale from very easy to very difficult (1-5)
|
21 days
|
|
Benefits to prosthetist - Adjustability
Time Frame: 21 days
|
Ease of adjustability ranked from difficult to easy (1-5)
|
21 days
|
|
Benefits to Patient - Mobility
Time Frame: 21 days
|
Measured by Amputee Mobility Predictor Assessment Tool
|
21 days
|
|
Benefits to Patient - Cosmesis
Time Frame: 21 days
|
Measured by Cosmesis survey question ranked from very unattractive to very attractive (1-5)
|
21 days
|
|
Benefits to patient - Number of Visits
Time Frame: 21 days
|
Measured as number of visits to achieve adequate fit in days
|
21 days
|
|
Device Safety - Composite of Device Related Adverse Events
Time Frame: 21 days
|
Composite of device related Adverse Events (DAE) assessed throughout 21 days after prosthetic fitting.
DAE is defined as a composite of all cause death, socket site skin problems that prevent wearing a prosthetic, socket site infection, and falls due to socket malfunction that result in injury.
|
21 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Gary Berke, MS, CP, FAAOP, Medical Creations
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 16, 2021
Primary Completion (Actual)
May 11, 2022
Study Completion (Actual)
June 24, 2022
Study Registration Dates
First Submitted
December 6, 2021
First Submitted That Met QC Criteria
January 11, 2022
First Posted (Actual)
January 13, 2022
Study Record Updates
Last Update Posted (Actual)
August 24, 2022
Last Update Submitted That Met QC Criteria
August 22, 2022
Last Verified
August 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- CP-0001
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
Yes
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.